2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow White Dot Syndromes: new trials by email Literature Review of White Dot Syndromes trials Research Report on White Dot Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
| Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 58 | 2007-09-01 | 2013-01-23 |
Birdshot Chorioretinopathy (2) · Behcet Syndrome (1) · Macular Edema (1) · Multifocal Choroiditis (1) · Ophthalmia, Sympathetic (1) · Panuveitis (1) · Retinal Vasculitis (1) · Sarcoidosis (1) · Uveitis (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1)
Autoimmune Diseases (2) · Chorioretinitis (2) · Choroid Diseases (2) · Choroiditis (2) · Eye Diseases (2) · Immune System Diseases (2) · Retinal Diseases (2) · Retinitis (2) · Uveal Diseases (2) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1) · Hereditary Autoinflammatory Diseases (1)
Interferon alpha-2 (1) · Prednisone (1) · secukinumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Novartis Pharmaceuticals (1)
France (1) · Germany (1) · United States (1)